Neuroone Medical Technologies annual gross margin
2010
2011
2012
2013
2021
2022
2023
2024
2025
Neuroone Medical Technologies Gross Margin Growth & History (NMTC)
Neuroone Medical Technologies's gross margin was 56.51% for fiscal 2025.
View full Neuroone Medical Technologies company overviewNeuroone Medical Technologies annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | 56.51% | +25.25 pp |
| 2024 | 2024-09-30 | 31.27% | +7.89 pp |
| 2023 | 2023-09-30 | 23.38% | +64.74 pp |
| 2022 | 2022-09-30 | −41.36% | +13.51 pp |
| 2021 | 2021-09-30 | −54.87% | −154.87 pp |
| 2013 | 2013-12-31 | 100.00% | 0.00 pp |
| 2012 | 2012-12-31 | 100.00% | +39.61 pp |
| 2011 | 2011-12-31 | 60.39% | −39.61 pp |
| 2010 | 2010-12-31 | 100.00% | — |
Neuroone Medical Technologies quarterly gross margin
Q1.11
Q3.11
Q1.12
Q3.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-06-30 | 59.94% | +6.00 pp |
| Q2 2026 | 2026-03-31 | 53.18% | −2.43 pp |
| Q1 2026 | 2025-12-31 | 54.20% | −4.65 pp |
| Q4 2025 | 2025-09-30 | 55.77% | +3.96 pp |
| Q3 2025 | 2025-06-30 | 53.94% | +19.80 pp |
| Q2 2025 | 2025-03-31 | 55.61% | +27.26 pp |
| Q1 2025 | 2024-12-31 | 58.85% | +31.61 pp |
| Q4 2024 | 2024-09-30 | 51.81% | +25.70 pp |
| Q3 2024 | 2024-06-30 | 34.13% | −4.55 pp |
| Q2 2024 | 2024-03-31 | 28.35% | +21.59 pp |
| Q1 2024 | 2023-12-31 | 27.24% | +37.98 pp |
| Q4 2023 | 2023-09-30 | 26.11% | +48.00 pp |
| Q3 2023 | 2023-06-30 | 38.68% | +58.69 pp |
| Q2 2023 | 2023-03-31 | 6.76% | +105.77 pp |
| Q1 2023 | 2022-12-31 | −10.74% | +28.06 pp |
| Q4 2022 | 2022-09-30 | −21.90% | +13.54 pp |
| Q3 2022 | 2022-06-30 | −20.01% | +34.46 pp |
| Q2 2022 | 2022-03-31 | −99.01% | +16.79 pp |
| Q1 2022 | 2021-12-31 | −38.81% | +13.88 pp |
| Q4 2021 | 2021-09-30 | −35.44% | −135.44 pp |
| Q3 2021 | 2021-06-30 | −54.47% | −154.47 pp |
| Q2 2021 | 2021-03-31 | −115.81% | −215.81 pp |
| Q1 2021 | 2020-12-31 | −52.69% | −152.69 pp |
| Q3 2014 | 2014-09-30 | 100.00% | 0.00 pp |
| Q2 2014 | 2014-06-30 | 100.00% | 0.00 pp |
| Q1 2014 | 2014-03-31 | 100.00% | 0.00 pp |
| Q4 2013 | 2013-12-31 | 100.00% | 0.00 pp |
| Q3 2013 | 2013-09-30 | 100.00% | 0.00 pp |
| Q2 2013 | 2013-06-30 | 100.00% | 0.00 pp |
| Q1 2013 | 2013-03-31 | 100.00% | 0.00 pp |
| Q3 2012 | 2012-09-30 | 100.00% | — |
| Q1 2012 | 2012-03-31 | 100.00% | — |
| Q3 2011 | 2011-09-30 | 100.00% | — |
| Q1 2011 | 2011-03-31 | 100.00% | — |
Neuroone Medical Technologies gross margin trends
Over the last five reported fiscal years, Neuroone Medical Technologies's gross margin decreased from 100.00% to 56.51%, a change of −43.49 percentage points. The latest reported quarter, Q3 2026, shows 59.94%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuroone Medical Technologies filings at SEC.gov ↗